coyatherapeutics.com
  • About Us
      • Back
      • Story and Approach
      • Management Team
  • Science & Technology
      • Back
      • Treg Overview
      • Manufacturing Overview
      • Exosome Overview
      • Publications
  • Pipeline
      • Back
      • Pipeline
      • Indications
  • News
      • Back
      • News
      • Press Releases
      • Blog
      • Presentations
      • Events
  • Patient Resources
      • Back
      • Clinical Trial Information
  • Contact Us
line

news

Science News
The ALS Association, Muscular Dystrophy Association, and ALS Finding a Cure Provide Additional Funding for Novel ALS Research
coyatherapeutics.com
Science News
Coya Raises $10M to Advance T-cell Therapy Now in Phase 2 ALS Trial
coyatherapeutics.com
Science News
Senior AbbVie liaison quits job to launch neuro startup, with sights set on ALS
coyatherapeutics.com
Science News
The ALS Association, ALS Finding A Cure, and MDA Co-Fund Clinical Trial Grant to Study Restoring Immune System Function to Treat ALS
coyatherapeutics.com
Science News
Houston Neurologist Discovers Treatment That Could Halt The Progression of ALS
coyatherapeutics.com
Science News
Breakthroughs That May Beat ALS [Opinion]
coyatherapeutics.com
New Immunotherapy Treatment Funded By The Ice Bucket Challenge May Help ALS Patients
coyatherapeutics.com
Science News
Houston Methodist Study Shows Positive Results In Slowing ALS Progression
coyatherapeutics.com
ALS: Immune Cells May Slow Disease Progression
coyatherapeutics.com
Scientific Journal
Boosting immune system cells could offer a new approach to treating Lou Gehrig’s disease
coyatherapeutics.com
Immune Cells Hold Promise In Slowing Down ALS
coyatherapeutics.com

Harnessing adoptive
regulatory T cells (Tregs)
to target disease

Contact Us
Gantry 5
© 2022 Coya Therapeutics, Inc. All rights reserved
  • About Us
      • Back
      • Story and Approach
      • Management Team
  • Science & Technology
      • Back
      • Treg Overview
      • Manufacturing Overview
      • Exosome Overview
      • Publications
  • Pipeline
      • Back
      • Pipeline
      • Indications
  • News
      • Back
      • News
      • Press Releases
      • Blog
      • Presentations
      • Events
  • Patient Resources
      • Back
      • Clinical Trial Information
  • Contact Us
Terms of Use  Privacy Policy  

Follow Us

5850 San Felipe St Suite 500
Houston TX 77057
1 (800) 587-8170

Harnessing potent
immunomodulatory T cells (Tregs) and TREG derived
Exosomes to target disease

Contact Us